Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
E
Economic TimesVerified Publisher
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil